Morgan Stanley invests Rs 26 crore in a smallcap multibagger riding on LGD wave

Global investment giant Morgan Stanley Asia (Singapore) has invested Rs 26.30 crore (Rs 26,29,99,770) in Goldiam International, a company riding the growth wave of the lab-grown diamonds (LGDs) sector. Goldiam’s stock has already delivered an impressive 188% return to investors over the past two years.

The investment formed part of Goldiam’s Qualified Institutional Placement (QIP), which raised approximately Rs 202 crore to fund expansion of its consumer-facing LGD brand, ORIGEM. The brand is expected to scale rapidly over the next 18–24 months, with plans to open 70–90 stores across India, tapping into the country’s nascent but fast-growing LGD retail market.

Morgan Stanley, one of the world’s largest institutional investors, emerged as a key participant in the QIP, subscribing to 79,969 shares at Rs 330 apiece (including a premium of Rs 328). Its investment accounted for a significant share of the total funds raised.


Other marquee investors also backed the fundraising, signaling confidence in Goldiam’s growth plans. Saint Capital Fund was allotted 2,42,424 shares, nearly 40% of the total issue size, while LC Pharos Multi Strategy Fund, Nova Global Opportunities Fund, and others also participated.

With rising global demand for sustainable, ethical, and affordable alternatives to mined diamonds, LGDs are gaining strong traction. Goldiam, already an established diamond manufacturer, is increasingly pivoting toward this segment. Its strategy to expand ORIGEM through physical retail and digital platforms aligns with shifting consumer preferences and India’s deep-rooted appetite for diamonds.

Also read: Rekha Jhunjhunwala sold Nazara before gaming ban but Nikhil Kamath, Madhusudan Kela held on

(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of The Economic Times)